For breast cancer survivors, post-surgery bras are a daily reality. Yet, women must choose from limited options that are mostly clinical-looking and often only available in medical stores.
Solution
We empower survivors with fashion-forward designs, easily accessible online and in mainstream stores, helping them reclaim femininity, comfort and emotional well-being.
Addressable Consumer Funnel (Europe, UK and the US)
~650K
Annual Breast Cancer Diagnoses
~364K
Annual Mastectomy Surgeries
5 Years
Minimal Survival Rate
~1.8M Women Total Addressable Annual Customer Pool
Market Data Sources: Europa Donna (2024), National Breast Cancer Foundation (2025), JAMA Surgery (2023), Breast Cancer Research Foundation (2025), Annals of Oncology (2025)
Market Size & Potential
2025
2030 Projection with CAGR of 7.7%
Market Data Sources:Annals of Oncology (March 2025). "European cancer mortality predictions for the year 2025 with focus on breast cancer."
Market Opportunity
The market for post-surgery bras represents a significant opportunity, characterized by competitors' limited product offerings for modern women and weak online distribution.
Underserved Niche
This niche is currently dominated by a few legacy brands, whose product lines are restrictive and whose designs often fail to meet the aesthetic and functional demands of modern consumers.
Competitor Online Gap
Our main competitors have traditionally relied on wholesale distribution. This existing model limits their ability to effectively enter the online market, despite Direct-to-Consumer (DTC) being the fastest-growing sales channel.
Traction
+60K Units Sold
PMF (Product Market Fit)
8 Countries
Sales Geography
+200 Retailers
Established network of loyal B2B clients
5 Sales Agents
Netherlands, Belgium, UK, FInland, US
€1.96 million
Revenue
€380k (2023) €730K (2024) €850K (2025)
9% EBITDA
Profitable - Ready to Scale
Why We Win
Fashion Aesthetic
Breaking from traditional clinical designs, Megami offers fashion-forward bras that embrace modern aesthetics, catering to the demands of contemporary women.
Uplifting Shopping Experience
We offer an uplifting shopping experience by selling through lingerie stores, boutiques, and department stores, rather than solely through medical outlets, unlike traditional brands.
DTC-Native Approach
Our Direct-to-Consumer approach enables rapid global scaling, maximized profit margins, direct customer relationships, and agile new product launches.
Innovation & Disruption
Committed to constant innovation, we leverage AI in business processes and product design as well as advanced e-commerce technology such as virtual fitting (demo).
Business Model
R&D
Product innovation, design, and sourcing are driven from Frankfurt, Germany and Hong Kong.
(4-6 months)
Production
Manufacturing is conducted through subcontracting with trusted suppliers in China.
(3 months)
Fulfillment
Our warehouse near Frankfurt handles European B2B and DTC orders. Our 3PL in China fulfills global DTC and Export wholesale.
Multi-channel Distribution
Global DTC through our Online Store.
B2B sales to direct clients and through Sales Agents.
Export wholesale to Distributors (FOB).
Leadership Team
Sergey Bakin
Co-Founder & CEO 8 years in the lingerie industry. Expertise in product development and brand building.
Huw Jones
Co-Founder & Strategic Advisor 7 years in sales. Expertise in strategic partnerships.
Jane Fainberg
PR & Corporate Communications
MBA in Marketing. 10 years experience in the healthcare industry. Leads community building and media relations.
Claudia de Groot
Global Scaling Lead 15 years in fashion and lingerie. Drives international expansion through growing sales agents network.
Leonid Bakin
Sales Director 10 years of sales experience. Responsible for wholesale across Europe and key account partnerships.
2026 Key Hires: E-commerce Lead and Social Media Lead.
Financial Ask & Use of Funds
We are seeking a strategic investment of €500K in Q4 2025 to scale up our B2B sales and establish online dominance in the post-surgery niche.
This capital will be allocated towards:
Launch of Direct-to-Consumer sales - €150K
Inventory stock up - €200K
B2B scaling (Expos) - €100K
R&D & Innovation - €50K
A more detailed breakdown of fund utilization can be provided upon request.
P&L Projection: 2026-2030
Investment Options
We are offering 2 compelling investment pathways: a direct equity stake and/or a convertible loan.
Vision
To establish Megami as the online category leader in post-surgery intimate wear, serving breast cancer survivors with fashion-forward designs that restore confidence and femininity.
Further Expansion Opportunity
Our expertise, community trust and DTC infrastructure will enable us to expand into further high-growth intimates niches such as wellness and activewear.
Connect With Us
We are seeking a long-term financial partner to collaborate on the current and upcoming projects. As an early investor, you’ll have the right to participate in future funding rounds to maintain your ownership percentage.